Saturday, April 21, 2018

Clairety - This is "Legit"

Image result for clairety ico

Clairety - This is "Legit"


Clairety, found online at ClairetyAI.com, aims to create an autonomous rating system for social media content. Find out how it works today in our review.
Clairety is a rating agency for social media content. The platform uses artificial intelligence to track the credibility of all 500,000,000 social media contributors in the world today, then reports that data to you with a browser module that embeds ratings directly within your social media content.
Picture scrolling through Twitter, for example, and seeing a controversial tweet about politics. That tweet is accompanied with a rating that gives you an overview of that person’s reputation. Today on Twitter, tweets from any account appear pretty much the same way. Under Clairety, you can get a better idea of which social media posts come from trusted sources – and which tweets come from known propagandists, low-quality news sources, and trolls.
A token sale for Clairety’s RELY tokens began on March 20, 2018.
Obviously, that’s an ambitious goal – so let’s take a closer look at how Clairety plans to accomplish that goal.

What Is Clairety And How Does It Work?

Clairety is based on a fully automated system. That system is completely unbiased and uses no human interactions.
Clairety will identify bots, spam, harassment, extreme speech, and other “low value” content posted online. Here’s how the company explains its system on its official website:
“We can separate facts from opinions, expertise from marketing, and the ‘real story’ from conspiracy theory. We let you know who is risky to believe, and who isn’t providing real economic value to social media consumers, publishers, advertisers, and those hoping to better understand social media and the marketplace of ideas.”
Clairety can be applied to all social media across industries. However, the developers want to specifically target the cryptocurrency space. Cryptocurrency has one of the most toxic social media communities on the internet today. Bitcoin (BTC) supporters trash “Bcash” supporters. Major industry figures are treated as heroes by some and scam artists by others. It’s hard to separate truth from fiction.
As the Clairety website explains, “the crypto space needs a credibility boost. We’re here to help provide it.”
Clairety will start by launching a crypto-specific dataset. That dataset will initially target low-volume specialty social media forums like Cointalk. That dataset, which was specifically designed for quantitative trading, can tell you who to believe and who to avoid on social media.
The ecosystem revolves around the use of ERC20 tokens called RELY.

Clairety Features and Benefits

Clairety aims to offer all of the following features and benefits to the world of social media:
Credibility: Clairety aims to make social media more credible by helping sort truthful sources from non-truthful sources, sorting sources who provide economic value from those who provide no value.
Real Economic Value: Social media is plagued by bots, automated accounts, trolls, and tweet farms that spam RTs and similar endorsements. Clairety claims its system clearly identifies these users, providing real economic value to both social media users and advertisers.
Truly Unbiased: Of course, the big problem with “ranking” quality on social media is that it opens the door for bias. Someone might get a low rating because they have a controversial political opinion, for example. Clairety claims this won’t be an issue on its platform because the platform uses AI that has no views or biases of its own. The system runs without human interaction. Social media users are ranked relative to other users based on the value they provide to a community.
Commercially Proven: Clairety’s automated algorithm was previously used to analyze financial markets. The company claims their system is commercially proven because the core logic has been used in financial markets where it read newswires for program trading systems.
Independent: Clairety claims they’ll never make content or sell content. The only goal of the platform is to tell users what is safe and reliable.
Support Crypto Traders: Clairety’s crypto trading dataset will tell you who to trust. Theoretically, this will allow genuine, high-quality cryptocurrency traders to rise to the top, while “pump and dumpers” and “shills” will sink to the bottom. This advances our community as a whole.

How Do RELY Tokens Work?

RELY tokens are solely a means of payment for Clairety’s service. They’re utility tokens that can be used to purchase products and services from Clairety. They do not confer voting rights or ownership in the platform.
You can purchase 100 Reliance tokens for the following products:
  • 1 year of CSMF Data Factors with unlimited usage (price set at 0.05 BTC) and one of the following two items:
  • 2 years of Premium Retail Service (price set at $96 USD)
  • 3 months of Small Business DaaS (price set at $100 USD)
Proceeds from the Clairety RELY token ICO will be used to develop the platform.

The RELY Token ICO

There’s a total supply of 34 million RELY tokens. Tokens will be sold at an initial exchange rate of $0.50 USD apiece. RELY tokens are ERC20 tokens on the Ethereum blockchain.
There’s a fixed token supply. RELY tokens are 100% pre-mined, and any unsold or unallocated tokens will be burned.
Clairety is seeking to raise a minimum of $2 million from its token sale and a maximum (hard cap) of $11 million.
The token sale began on March 20 with a private pre-sale. That pre-sale will continue for four weeks, then followed by a public sale in mid-April for four more weeks. The token sale period ends on May 14, 2018.

Who’s Behind Clairety?

Clairety is led by CEO and CTO Tom Costello, who started his career as a quantitative analyst and developer at JPMorgan. He eventually moved to hedge fund management, taking a research position at Moore Capital before managing money under Caxton Associates and Tudor Investments, where he was responsible for a $100 million quantitative trading strategy he designed himself. That strategy was based on a “news reading” system. The core logic of that news reading system is used in Clairety’s social media analysis system today.
The other listed member of the executive team is Randall Brown (CFO), who served as Head of Rates, Sales, and Trading for Mistubishi UFJ Securities, where he was responsible for all aspects of funding, risk management, and oversight of the bank’s US fixed income trading operations.
Clairety is based in New York City. The company was founded in 2017.

Clairety Conclusion

Clairety aims to provide “clairety” in the world of social media by assigning ratings and reputation scores to online accounts. These scores will not be calculated by humans, but instead by bots and AI. This AI will quantitatively analyze an individual’s social media presence to determine their value to the community. The end result is a social media where bots, trolls, and spammers are ranked low, while those who contribute genuine value are ranked high.
Clairety will initially focus on the cryptocurrency industry – an industry that sorely needs a cleanup of its social media presence. Clairety aims to promote genuine cryptocurrency traders while forcing shills, pump and dumpers, and other spammers to the bottom.


Hope that this article could help you determine whether this is a good project to invest on or not. To know more of them you could visit these links below.

Website : http://clairetyai.com/

Whitepaper : http://clairetyai.com/img/Clairety%20Whitepaper%20V1.1.pdf

Telegram : https://t.me/clairetyAI



CREATOR
aervin11
https://bitcointalk.org/index.php?action=profile;u=1196880

Tuesday, April 10, 2018

Shivom - Healthier World

Shivom - Healthier World

I know that you are still confused about how Shivom - building the largest genomic and health data hub on the blockchain would help us in terms of medical attention. Here I will try to tell you more about Shivom and how could this be possible and useful in the blockchain, using the blockchain.


First, What is Genome/Genomic Medicine?

It is an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (e.g., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use." Already, genomic medicine is making an impact in the fields of oncology, pharmacology, rare and undiagnosed diseases, and infectious disease.


How the blockchain could help Genomic Medicine?

As you know, blockchain is a public ledger that could be seen by all people around the planet also, there is no third party could intervene on the transaction that is happening. Blockchain is just a program, open to all innovations to change and improve daily lives, and this is the opportunity taken by Shivom. Anonymously hiding the owners identity BUT showing it's health issues around the globe and the medication being made is a huge opportunity and open to innovations healthcare that Shivom wanted to promote. ( See whitepaper for more detailed information of infographic charts )


These are the things that Shivom wants to happen

- Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available.

- The solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.

- Have partnered with the top developers and healthcare organizations, and technology companies and big pharma are already lining up to take advantage of our unique genomics and healthcare approach. As Shivom scales up and goes global, we have many more partnerships already in development.

- The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.


To make those things possible for the project's development, they are currently conducting an ICO/crowdfunding that would let people to invest and be a part of Shivom's success.

Here are some information's about their Token Sale.

The Goal
Durning the ICO, they are having cap's that would determine on how much they would want to raise and on how much would they sell their tokens.
Softcap: 15,000 ETH
Hardcap: 75,000 ETH
Price: 7,000 OMX / ETH
Pre-sale: 16th April — 22nd April (pre-sale terms not yet officially released)
Public sale: Not officially released

Token distribution
• 3 billion tokens to be distributed
• 90M OmiX to the community
• 420M OmiX to founders
• 300M OmiX to advisors
• 600M OmiX for Incentivizing Growth Pool
• 600M OmiX to Company Reserve

*** Number of OmiX tokens at ICO not stated however appears to be 990M MAX ***


Having the transparent crowdfunding visible to all using the blockchain, the proceeds of the ICO would go to ....

ICO funds distribution nominated as being:
• 20% — platform development
• 11% — operations and business development
• 10% — non profit R&D
• 21% — partnerships and marketing
• 5% — legal
• 2% — proof of concept
• 6% — data storage
• 25% — laboratories

*** Founder and advisor tokens are locked for between 18 months and 3 years dependant upon their involvement in the project and stage of entry into the company. ***


The OmiX token enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system. Tokens offer the following:
• Ability to acquire premium services in the Shivom ecosystem
• Ability to acquire genome sequencing kits
• Ability to sponsor sequencing projects
• Ability to acquire access to health/fitness apps from 3rd party providers
• Ability to access the genome database
• Ability to pay donors for data/participation in research studies
• Ability for service providers to use the platform


The Catch

The OmiX token enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system. Tokens offer the following:
• Ability to acquire premium services in the Shivom ecosystem
• Ability to acquire genome sequencing kits
• Ability to sponsor sequencing projects
• Ability to acquire access to health/fitness apps from 3rd party providers
• Ability to access the genome database
• Ability to pay donors for data/participation in research studies
• Ability for service providers to use the platform

Pro's
• A potentially large market given world population however I’m not sure that too many care enough about genome sequencing for this market size to be realised. The team are however aware of this and research shows one of the biggest barriers for people when considering genomic testing is the security of their data. The blockchain solution offered by Shivom should resolve this problem.

• Recent partnership announced with Genetic Technologies Ltd (GTG), which is a publicly listed Australian company providing a clinically validated risk assessment test for non-hereditary breast cancer. This partnership provides Shivom with access to GTG’s accredited laboratory in Victoria, Australia. GTG will also become part of Shivom’s global genetic counselling network and obtain access to Shivom’s pool of genomic data. This also extends to GTG accredited facilities in the US.

• Recent MoU signed with the Government of Andhra Pradesh, which ‘explores the possibility of providing diagnostic services to patients of Andhra Pradesh by maintaining the privacy of the individual data through blockchain technologies’. It will also focus on shifting from using genomic data for research to using this data for predictive healthcare in a preventative approach. A part of this deal gives Shivom access to conduct pilot testing in the Andhra Pradesh cancer research centre working direct with government.

• A partnership with DeHedge in which Shivom will be the first token offered as a hedged token on their platform. This protects contributors (to some degree) from volatility and risk. The DeHedge team also stringently vet projects before accepting them onto their platform so this also offers some degree of certainty and trust in the Shivom project.

• Strategic technical partnerships with Ocean Protocol and Spherity Protocol.


Con's
• The majority of team members have at least one other project running concurrent to Shivom. Per Lind is particularly concerning with his LinkedIn profile listing involvement in a further 10 projects (including IOTA) from co-founder to partner, VP and director of these other organisations.

• 990M tokens available for ICO yet 600M are allocated for ‘incentives’ and another 600M for ‘company reserves’. In my opinion these numbers seem too high and I feel the incentives (bounty programs mentioned) will dilute the value of the tokens sold during ICO.


Hope that this article could help you determine whether this is a good project to invest on or not. To know more of them you could visit these links below.


Website : https://shivom.io/

Telegram : https://t.me/projshivom

Facebook : https://www.facebook.com/ProjectShivom

Twitter : https://twitter.com/projectshivom

Instagram : https://www.instagram.com/projectshivom

Reddit : https://www.reddit.com/r/Shivom/

Youtube Channel : https://www.youtube.com/c/ProjectShivom

Bitcointalk : https://bitcointalk.org/index.php?topic=2365709.msg24124494#msg24124494

CREATOR
aervin11
https://bitcointalk.org/index.php?action=profile;u=1196880